Skip to content

Transcutaneous Electrical Acupoint Stimulation to Improve Pregnancy Rates for Women Undergoing in Vitro Fertilization

Transcutaneous Electrical Acupoint Stimulation to Improve Pregnancy Rates for Women Undergoing in Vitro Fertilization

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01608048
Enrollment
384
Registered
2012-05-30
Start date
2014-05-31
Completion date
2017-02-28
Last updated
2014-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supervision of Pregnancy Resulting From In-vitro Fertilization

Keywords

In-vitro Fertilization, transcutaneous electrical acupoint stimulation

Brief summary

The objective of this study is to investigate the effect of transcutaneous electrical acupoint stimulation on pregnancy rates in women undergoing in vitro fertilization.

Interventions

DEVICEtranscutaneous electrical acupoint stimulation (TEAS);EA

TEAS group (conventional IVF + TEAS), electro-acupuncture (EA) group (conventional IVF + electro-Acu.), and control group (only conventional IVF) Parameter of TEAS or EA: frequency of 2/100 Hz;moderate electrical current. Treatments start from the day 3 of menstruation,once every two days, 30 min for each for two continuous weeks.

Sponsors

Wuhan General Hospital of Guangzhou Military Command
CollaboratorOTHER
Huazhong University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

(1) infertile women \< 40 years of age, undergoing a fresh IVF or intracytoplasmic sperm injection (ICSI) cycle; (2) be an appropriate candidate with the potential for a lower success rate which defined as two or more previous unsuccessful ETs (fresh or frozen); (3) are willing to sign an informed consent form, indicating that they are aware of the investigational nature of this study that is in keeping with the policies of the institution; (4) willing to return to the study site for their study visits. The reason for our inclusion criteria is that women experienced several unsuccessful OAs or ETs may easily accept randomization to this study, and for whom adding TEAS or EA may significantly improve their clinical outcomes.

Exclusion criteria

(1) major medical illnesses (like stage III heart disease, severe hypertension, uncontrolled diabetes mellitus, HIV positivity, severe bleeding dyscrasias, etc.) possibly precluding IVF or pregnancy; (2) FSH more than 20 IU/L; (3) receiving donor eggs; (4) cutaneous lesion of certain acupoint area; (5) having been previously participated in this study or having undertaken acupuncture (in whatever modality) treatment for infertility.

Design outcomes

Primary

MeasureTime frame
clinical pregnancy rate (CPR)1 year

Secondary

MeasureTime frame
Live birth rate (LBR)2 years

Countries

China

Contacts

Primary ContactCui Hong Zheng, Doctor
635342693@qq.com86-27-83663275

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026